Company: BKYI
Filing Date: 2025-12-02
Form Type: 424B3
Source: 0001437749-25-036669
Chunk: 15

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-12-02
Form: 424B3
Chunk 15
---
 Series B warrants to purchase up to an aggregate of 1,545,834 shares of the Company’s common stock.

On October 27, 2025, we entered into a warrant exercise agreement with the selling stockholder to exercise certain outstanding warrants to purchase an aggregate of 3,091,668 shares of the Company’s common stock at a reduced exercise price of $1.02 per share, which were originally issued to the selling stockholder on January 15, 2025 with an exercise price of $2.15 per share. In consideration for the exercise of the existing warrants, the selling stockholder received new unregistered warrants to purchase up to an aggregate of 6,183,336 shares of the Company’s common stock at an exercise price of $1.02 per share. The Warrants are immediately exercisable and expire five years from the date of issuance. The shares underlying these warrants are the subject of this Registration Statement on Form S-1.

<div align='center'>PLAN OF DISTRIBUTION</div>

We are registering 6,183,336 shares of our common stock issuable upon the exercise of the Warrants held by the selling stockholder for possible resale from time to time. The selling stockholder will act independently of us in making decisions with respect to the timing, manner and size of each sale. The selling stockholder may, from time to time, sell any or all of its shares of common stock covered by this prospectus on the Nasdaq Capital Market or any other stock exchange, market, or trading facility on which the shares are traded, or in private transactions. These sales may occur at fixed or negotiated prices. The selling stockholder may use any one or more of the following methods when selling shares:

| ● | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;                                                                                |
| ● | block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
| ● | purchases by a broker-dealer as principal and resale by the broker-dealer for its account;                                                                                      |
| ● | an exchange distribution in accordance with the rules of the Nasdaq Capital Market or any other applicable national securities exchange;                                        |
| ● | privately negotiated transactions;                                                                                                                                              |
| ● | short sales;                                                                                                                                                                    |
| ● | through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;                                                   |
| ● | broker